Clinical trial
RCT ALB for SA Cysticercosis
NCT00133458 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn
Key facts
| NCT number | NCT00133458 |
|---|---|
| Title | RCT ALB for SA Cysticercosis |
| Official title | Randomized, Double Blind Comparison of Two Lenghts of Albendazole Therapy for Subarachnoid Cysticercosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Subarachnoid Cysticercosis |
| Intervention type | Drug |
| Interventions | Albendazole |
| Enrollment | 0 |
| Completion | Jun 1, 2007 |
| First posted | Aug 23, 2005 |
| Last update posted | Jan 30, 2019 |
| Countries | Brazil, Colombia, Ecuador, Peru |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: